The UAE administered the third dose to a ‘small number’ of people who did not develop coronavirus antibodies after the first two shootings at Sinopharm, The National newspaper reported.
The United Arab Emirates plans to offer a third Sinopharm shot to people who have already taken two doses, amid concerns over the effectiveness of the vaccine which is the cornerstone of the country’s rapid inoculation program.
“An additional support dose of Sinopharm is now available to people who have received the vaccine before and who have now completed more than six months from the second dose,” according to the UAE’s National Emergency Crisis and Disaster Management Authority.
Sinopharm Group Co. in China won World Health Organization support for the vaccine this month, but there are questions about how the shot, while protecting individuals from the development of severe Covid-19, could help prevent the virus from transferring and infecting many people.
The UAE administered the third dose to a “small number” of people who had not developed antibodies after the first two shootings at Sinopharm, the National newspaper reported in March. Sinopharm’s effectiveness for symptom prevention and hospitalized disease is estimated at 79% in all age groups combined, according to the WHO.
Other vaccine makers are also racing to improve booster shots. It’s not yet clear when or if it will be necessary, or who will get it if they are, but companies are preparing for a scenario where the virus is constantly evolving and arrows may be needed. -period booster shot.
Peng Xiao, chief executive of G42, the company that makes Sinopharm shot locally in the UAE, told Bloomberg in March that the company was “testing whether the third shooting would help protect against new mutations. to be seen all around. “
The UAE has one of the fastest vaccine launches in the world, delivering more than 11.5 million doses to its population of about 10 million. Infections fell by more than 65% from an increase in January and the country reported the smallest increase in cases this year on Monday.
Vaccines from Pfizer Inc. and AstraZeneca Plc are approved for use, although the UAE inoculation program is at Sinopharm, which is conducted locally.
The Sinopharm shot causes almost 60% of the doses administered in the Seychelles, vaccinating more of its population than any other country in the world but still needs to restore some virus -related curbs as the cases.
Increasing the caseload raises efficiency concerns. Seychelles also uses the AstraZeneca vaccine.